Bayer Women's Low Dose Plus Calcium Interactions
There are 473 drugs known to interact with Bayer Women's Low Dose Plus Calcium (aspirin / calcium carbonate), along with 14 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 65 are major, 351 are moderate, and 57 are minor.
- View all 473 medications that may interact with Bayer Women's Low Dose Plus Calcium
- View Bayer Women's Low Dose Plus Calcium alcohol/food interactions (3)
- View Bayer Women's Low Dose Plus Calcium disease interactions (14)
Most frequently checked interactions
View interaction reports for Bayer Women's Low Dose Plus Calcium (aspirin / calcium carbonate) and the medicines listed below.
- acetaminophen / hydrocodone
- albuterol
- alprazolam
- amlodipine
- amoxicillin
- atenolol
- atorvastatin
- bupropion
- calcium / vitamin d
- Centrum Silver (multivitamin with minerals)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- D3 (cholecalciferol)
- folic acid
- furosemide
- gabapentin
- hydrochlorothiazide
- levothyroxine
- lisinopril
- metformin
- Metoprolol Tartrate (metoprolol)
- omeprazole
- prednisone
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- zolpidem
- Zyrtec (cetirizine)
Bayer Women's Low Dose Plus Calcium alcohol/food interactions
There are 3 alcohol/food interactions with Bayer Women's Low Dose Plus Calcium (aspirin / calcium carbonate).
Bayer Women's Low Dose Plus Calcium disease interactions
There are 14 disease interactions with Bayer Women's Low Dose Plus Calcium (aspirin / calcium carbonate) which include:
- coagulation
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.